Home › Recall events › Plantimex Recalls Mamisan Lidocaine Ointment Containers Due…
Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child…
CPSC · December 18, 2025
- Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates… — CPSC recall announced .
- Hazard: The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant,….
- Units affected: About 50,330.
- Remedy: Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact….
- Details as of ; the linked official notice is authoritative for lot codes, VINs, and remedies.
- Agency
- CPSC
- Posted
- Status
- Consumers should immediately secure the recalled ointment…
- Recalling firm
- MiramarLab, of Doral, Florida
- Source ID
- 26157
Description
This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.
- Products
- Mamisan Pain Relieving Topical Ointment
- Sold at
- Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.
- Manufactured by
- MiramarLab, of Doral, Florida
- Incidents
- None reported
Related: Product recalls · All recall events